Adjuvant ovarian function suppression in premenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2–negative early breast cancer: a multi-center retrospective study
The CR-score model can effectively guide clinicians in making decisions regarding OFS for premenopausal patients with HR+/HER2- breast cancer.
Authors
- Debo Chen (ORCID: https://orcid.org/0000-0003-3524-063X)
- Weibin Lian
- Chengye Hong
- Liangqiang Li (ORCID: https://orcid.org/0000-0002-4307-4048)
Institutions
- Fujian Medical University (CN)
- Second Affiliated Hospital of Fujian Medical University (CN)
Publication Details
- Journal
- BMC Cancer
- Published
- 2025-04-17
- DOI
- https://doi.org/10.1186/s12885-025-14120-0
- Primary Topic
- Breast Cancer Treatment Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Quanzhou City Science and Technology Program